Block Biosciences
blockbiosciences.com
Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
FACIT
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
FACIT Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
ProTgen develops first-in-class targeted Notch activators that generate progenitor T cells to restore thymic function and immune competence.
Vetbiolix is a veterinary biotech developing first-in-class therapeutics for pets. Targeting Osteoarthritis, Periodontitis & Gut Motility…
Cancer Solved Together The Ontario Institute for Cancer Research (OICR) brings together a community of scientists, clinicians, patients and…
Invest in cutting-edge immunotherapy solutions targeting cancers and rheumatic diseases.
About Us Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics for a wide range of…
SignaCor, a UK based, clinical stage biotech company are pioneering a first-in-class therapeutic approach to symptomatic hypertrophic…